Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent

Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent

US Patent 10251836 · Granted Apr 9, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multiphasic contraceptive regimen for oral combination drug formulation of proge2025
Treatment of endometriosis by intravaginal administration of a low dose of a sel2024
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2023
Multiphasic contraceptive regimen for oral combination drug formulation of proge2023
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2022
Treatment of endometriosis by intravaginal administration of a low dose of a sel2021
Multiphasic contraceptive regimen for oral combination drug formulation of proge2021
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2020
Multiphasic contraceptive regimen for oral combination drug formulation of proge2020
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2020
Multiphasic contraceptive regimen for oral combination drug formulation of proge2019
Multiphasic contraceptive regimen for oral combination drug formulation of proge2018